Wegovy (semaglutide) It was the first weekly injectable GLP-1 approved specifically for weight management in adults with a body mass index of 30 or higher, or 27 and above with at least one weight-related condition such as high blood pressure or type 2 diabetes
Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W (1993) Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients
The process differs by institution, but the American Society for Metabolic and Bariatric Surgery offers guidelines
Pharmaceuticals (Basel) 17(12):1655 [DOI] [PMC free article] [PubMed] [Google Scholar] 70.Picoli CC, Tsibulnikov S, Ho M, Demambro V, Feng T, Eltahir M, Le PT, Chlebek C, Rosen CJ, Ryzhov S, Li Z (2025) Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice
Nonsurgical Treatment Strategies In our experience, the full range of nonsurgical modalities should be considered in weight loss patients